CANCELLED - SECTION 8
section 8
on 20 Sep 2024
Last Applicant/ Owned by
Zhongxiao E. Rd., Xinyi Dist.
Taipei City 110
TW
Serial Number
87091025 filed on 01st Jul 2016
Registration Number
5419038 registered on 06th Mar 2018
Correspondent Address
Joe McKinney Muncy
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
SYNEURX
Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of n Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services
First Use Date in General
14th Mar 2016
First Use Date in Commerce
14th Mar 2016
Class [005]
Pharmaceutical Products
Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes
First Use Date in General
31st May 2014
First Use Date in Commerce
31st May 2014
Mark Details
Serial Number
No 87091025
Mark Type
No Service Mark
Attorney Docket Number
No 5454/0173TUS
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Sep 2024 | CANCELLED SEC. 8 (6-YR) |
| 06th Mar 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 28th Dec 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 28th Dec 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 28th Dec 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 28th Dec 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd Dec 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd Dec 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 23rd Dec 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 23rd Dec 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |